Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,152 | 255 | 83.9% |
| Travel and Lodging | $788.35 | 2 | 12.8% |
| Education | $200.52 | 9 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,042 | 55 | $0 (2024) |
| Amgen Inc. | $990.54 | 16 | $0 (2024) |
| Vifor Pharma, Inc. | $506.24 | 23 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $473.67 | 35 | $0 (2024) |
| Eurofins Viracor, Inc. | $446.05 | 3 | $0 (2019) |
| Fresenius USA Marketing, Inc. | $361.09 | 17 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $340.68 | 14 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $270.74 | 17 | $0 (2022) |
| NXSTAGE MEDICAL, INC. | $252.78 | 5 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $180.63 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $650.86 | 30 | AstraZeneca Pharmaceuticals LP ($163.49) |
| 2023 | $1,109 | 49 | AstraZeneca Pharmaceuticals LP ($234.51) |
| 2022 | $782.80 | 52 | Bayer HealthCare Pharmaceuticals Inc. ($211.38) |
| 2021 | $879.22 | 48 | AstraZeneca Pharmaceuticals LP ($276.62) |
| 2020 | $420.49 | 21 | Otsuka America Pharmaceutical, Inc. ($133.17) |
| 2019 | $602.55 | 22 | Eurofins Viracor, Inc. ($179.58) |
| 2018 | $387.62 | 24 | Mallinckrodt LLC ($76.79) |
| 2017 | $1,309 | 20 | Amgen Inc. ($837.15) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: CRITICAL CARE | ||||||
| 11/01/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.39 | General |
| 09/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Cardio-renal | ||||||
| 07/30/2024 | Fresenius USA Marketing, Inc. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $89.53 | General |
| Category: Nephrology | ||||||
| 07/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.15 | General |
| 06/28/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: CRITICAL CARE | ||||||
| 06/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Hyperkalemia | ||||||
| 05/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.20 | General |
| 04/12/2024 | NXSTAGE MEDICAL, INC. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $39.57 | General |
| Category: Nephrology | ||||||
| 04/11/2024 | NXSTAGE MEDICAL, INC. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Nephrology | ||||||
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Cardio-renal | ||||||
| 03/07/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $14.05 | General |
| Category: NEPHROLOGY | ||||||
| 03/06/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $24.21 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,657 | 3,856 | $484,930 | $187,160 |
| 2022 | 33 | 1,899 | 4,674 | $572,675 | $195,607 |
| 2021 | 32 | 2,034 | 4,879 | $657,805 | $259,127 |
| 2020 | 35 | 2,122 | 4,206 | $652,053 | $231,722 |
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 31 | 148 | $97,033 | $38,973 | 40.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 105 | 769 | $91,130 | $35,620 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 397 | $96,734 | $32,071 | 33.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 152 | 380 | $55,989 | $22,334 | 39.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 40 | $21,765 | $8,394 | 38.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 67 | 78 | $19,464 | $7,393 | 38.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 78 | 167 | $14,545 | $6,688 | 46.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 69 | 115 | $15,719 | $6,142 | 39.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 56 | $12,334 | $4,972 | 40.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 77 | 167 | $10,432 | $4,797 | 46.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 52 | 83 | $7,492 | $2,995 | 40.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $6,702 | $2,411 | 36.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 33 | 37 | $6,008 | $2,186 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 37 | $6,348 | $2,116 | 33.3% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 11 | 26 | $4,341 | $1,652 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,895 | $1,600 | 41.1% |
| 80069 | Kidney function blood test panel | Office | 2023 | 87 | 167 | $3,067 | $1,421 | 46.3% |
| 83735 | Magnesium level | Office | 2023 | 78 | 166 | $2,353 | $1,080 | 45.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 95 | 187 | $2,053 | $941.58 | 45.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 38 | 90 | $1,489 | $672.34 | 45.2% |
| 84156 | Total protein level, urine | Office | 2023 | 94 | 186 | $1,429 | $663.66 | 46.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 71 | 146 | $1,161 | $449.66 | 38.7% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 23 | 35 | $615.06 | $437.50 | 71.1% |
| 84100 | Phosphate level | Office | 2023 | 28 | 71 | $718.28 | $322.47 | 44.9% |
| 83540 | Iron level | Office | 2023 | 23 | 35 | $477.14 | $221.90 | 46.5% |
About Dr. John Ducker, MD
Dr. John Ducker, MD is a Nephrology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003868597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Ducker, MD has received a total of $6,141 in payments from pharmaceutical and medical device companies, with $650.86 received in 2024. These payments were reported across 266 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,152).
As a Medicare-enrolled provider, Ducker has provided services to 7,712 Medicare beneficiaries, totaling 17,615 services with total Medicare billing of $873,616. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Fort Wayne, IN
- Active Since 05/16/2006
- Last Updated 11/10/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1003868597
Products in Payments
- FARXIGA (Drug) $656.89
- Veltassa (Drug) $588.57
- Kerendia (Drug) $473.67
- LOKELMA (Drug) $367.06
- JYNARQUE (Drug) $351.45
- ACTHAR (Biological) $238.86
- Velphoro (Drug) $227.77
- KRYSTEXXA (Biological) $209.83
- Auryxia (Drug) $202.99
- LIBERTY SELECT CYCLER (Device) $181.24
- AURYXIA (Drug) $142.28
- RAYALDEE (Drug) $125.16
- NXSTAGE SYSTEM ONE (Device) $89.53
- INJECTAFER (Drug) $89.03
- LUPKYNIS (Drug) $82.95
- SYSTEM ONE (Device) $71.54
- Lexiscan (Drug) $70.72
- Parsabiv (Biological) $63.67
- Rayaldee (Drug) $55.47
- Renal - PD (Device) $54.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Fort Wayne
Andrew O'shaughnessy, Md, MD
Nephrology — Payments: $48,496
Dr. Melanie Barrido, M.d, M.D
Nephrology — Payments: $6,727
Irfan Munir
Nephrology — Payments: $5,900
Swapna Joseph, Md, MD
Nephrology — Payments: $5,598
Sajjad Habib, Md, MD
Nephrology — Payments: $4,830
Garima Gupta, Md, MD
Nephrology — Payments: $4,161